Carson W E, Giri J G, Lindemann M J, Linett M L, Ahdieh M, Paxton R, Anderson D, Eisenmann J, Grabstein K, Caligiuri M A
Department of Medicine, Roswell Park Cancer Institute, Buffalo, New York 14263.
J Exp Med. 1994 Oct 1;180(4):1395-403. doi: 10.1084/jem.180.4.1395.
Interleukin 15 (IL-15) is a novel cytokine that has recently been cloned and expressed. Whereas it has no sequence homology with IL-2, IL-15 interacts with components of the IL-2 receptor (IL-2R). In the present study we performed a functional analysis of recombinant IL-15 on phenotypically and functionally distinct populations of highly purified human natural killer (NK) cells. The CD56bright subset of human NK cells constitutively expresses the high affinity IL-2R and exhibits a brisk proliferative response after the binding of picomolar amounts of IL-2. Using a proliferation assay, IL-15 demonstrated a very steep dose-response curve that was distinct from the dose-response curve for IL-2. The proliferative effects of IL-15 could be abrogated by anti-IL-2R beta (p75), but not by anti-IL-2R alpha (p55). The proliferative effects of IL-2 on CD56bright NK cells could be inhibited by both antibodies. CD56dim NK cells express the intermediate affinity IL-2R in the absence of the high affinity IL-2R. Activation of CD56dim NK cells by IL-15 was similar to that of IL-2 as measured by enhanced NK cytotoxic activity, antibody-dependent cellular cytotoxicity, and NK cell production of interferon gamma, tumor necrosis factor alpha, and granulocyte/macrophage colony-stimulating factor. The IL-15-enhanced NK cytotoxic activity could be completely blocked by anti-IL-2R beta monoclonal antibody. The binding of radiolabeled IL-2 and IL-15 to CD56dim NK cells was inhibited in the presence of anti-IL-2R beta. Scatchard analysis of radiolabeled IL-15 and IL-2 binding to NK-enriched human lymphocytes revealed the presence of high and intermediate affinity receptors for both ligands. IL-15 is a ligand that activates human NK cells through components of the IL-2R in a pattern that is similar but not identical to that of IL-2. Unlike IL-2, IL-15 is produced by activated monocytes/macrophages. The discovery of IL-15 may increase our understanding of how monocytes/macrophages participate in the regulation of NK cell function.
白细胞介素15(IL-15)是一种最近被克隆和表达的新型细胞因子。尽管它与IL-2没有序列同源性,但IL-15可与IL-2受体(IL-2R)的组分相互作用。在本研究中,我们对重组IL-15作用于高度纯化的人自然杀伤(NK)细胞的表型和功能不同的群体进行了功能分析。人NK细胞的CD56bright亚群组成性表达高亲和力IL-2R,并在皮摩尔量的IL-2结合后表现出快速的增殖反应。使用增殖试验,IL-15显示出非常陡峭的剂量反应曲线,这与IL-2的剂量反应曲线不同。IL-15的增殖作用可被抗IL-2Rβ(p75)消除,但不能被抗IL-2Rα(p55)消除。IL-2对CD56bright NK细胞的增殖作用可被两种抗体均抑制。CD56dim NK细胞在缺乏高亲和力IL-2R的情况下表达中等亲和力IL-2R。通过增强的NK细胞毒性活性、抗体依赖性细胞毒性以及NK细胞产生干扰素γ、肿瘤坏死因子α和粒细胞/巨噬细胞集落刺激因子来衡量,IL-15对CD56dim NK细胞的激活与IL-2相似。IL-15增强的NK细胞毒性活性可被抗IL-2Rβ单克隆抗体完全阻断。在抗IL-2Rβ存在的情况下,放射性标记的IL-2和IL-15与CD56dim NK细胞的结合受到抑制。对放射性标记的IL-15和IL-2与富含NK的人淋巴细胞结合的Scatchard分析揭示了两种配体均存在高亲和力和中等亲和力受体。IL-15是一种通过IL-2R的组分激活人NK细胞的配体,其模式与IL-2相似但不完全相同。与IL-2不同,IL-15由活化的单核细胞/巨噬细胞产生。IL-15的发现可能会增加我们对单核细胞/巨噬细胞如何参与NK细胞功能调节的理解。